Belite Bio, Inc. (BLTE)

156.28 +1.78 (+1.15%) USD  |  NASDAQ  |  Dec 24, 12:16
More

Belite Bio SG&A Expense (TTM): 29.58M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Ocugen, Inc. 27.76M
Ionis Pharmaceuticals, Inc. 351.68M
INVO Fertility, Inc. 10.35M
IDEAYA Biosciences, Inc. 55.43M
Janux Therapeutics, Inc. 39.13M